Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication use

Objective: Examine long-term findings from two Phase III open-label extension (OLEx) studies of adjunctive perampanel in patients aged ≥60 years experiencing focal seizures (FS), with/without focal to bilateral tonic-clonic seizures (FBTCS), with/without enzyme-inducing anti-seizure medications (EIA...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rohit Marawar, Ilo E. Leppik, Robert T. Wechsler, Anna Patten, Leock Y. Ngo
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-12-01
Col·lecció:	Epilepsy & Behavior Reports
Matèries:	Epilepsy Adjunctive therapy Perampanel Focal to bilateral tonic-clonic seizures Older adults
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589986425000930
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!